DexCom (NASDAQ: DXCM) reported Q1 EPS of ($0.05), $0.11 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $280.5 million versus the consensus estimate of $246.39 million.

GUIDANCE:

DexCom sees FY2019 revenue of $1.25-1.3 billion, versus the consensus of $1.23 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.